Progress Toward Implementing the Product Identification Requirements of the Drug Supply Chain Security Act; Public Meeting; Request for Comments

Resumo

The Food and Drug Administration (FDA) is announcing a public meeting entitled "Progress Toward Implementing the Product Identification Requirements of the Drug Supply Chain Security Act." This public meeting is intended to provide members of the pharmaceutical distribution supply chain and other interested stakeholders an opportunity to share information with FDA about the efforts underway to implement the Drug Supply Chain Security Act's (DSCSA's) product identification requirements, including the use of product identifiers to enhance tracing at the product level.